|
1
|
Jennison Associates
New York
|
$231M
|
+$18.1M
|
+1,144,714
|
+10%
|
|
|
2
|
Rubric Capital Management (New York)
New York
|
$203M
|
–
|
–
|
–
|
|
|
3
|
Suvretta Capital Management
New York
|
$198M
|
-$16.7M
|
-1,057,582
|
-9%
|
|
|
4
|
Frazier Life Sciences Management
Palo Alto,
California
|
$186M
|
–
|
–
|
–
|
|
|
5
|
|
$162M
|
+$650K
|
+41,234
|
+0.5%
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$135M
|
+$1.53M
|
+96,991
|
+1%
|
|
|
7
|
Polar Capital Holdings
London,
United Kingdom
|
$99.9M
|
+$4.61M
|
+292,279
|
+6%
|
|
|
8
|
State Street
Boston,
Massachusetts
|
$87.5M
|
+$1.8M
|
+114,378
|
+3%
|
|
|
9
|
Gilder Gagnon Howe & Co
New York
|
$83.5M
|
+$4.31M
|
+273,345
|
+7%
|
|
|
10
|
|
$80.6M
|
-$601K
|
-38,136
|
-0.9%
|
|
|
11
|
UBS Group
Zurich,
Switzerland
|
$55.6M
|
+$166K
|
+10,499
|
+0.4%
|
|
|
12
|
Geode Capital Management
Boston,
Massachusetts
|
$49.1M
|
+$377K
|
+23,898
|
+0.9%
|
|
|
13
|
Janus Henderson Group
London,
|
$45.2M
|
+$2.11M
|
+134,071
|
+6%
|
|
|
14
|
Franklin Resources
San Mateo,
California
|
$43.6M
|
-$6.65M
|
-421,758
|
-15%
|
|
|
15
|
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
$40M
|
–
|
–
|
–
|
|
|
16
|
|
$39.9M
|
-$698K
|
-44,288
|
-2%
|
|
|
17
|
Perpetual Ltd
Sydney, New South Wales,
Australia
|
$38.2M
|
+$31.5M
|
+1,998,086
|
+7,534%
|
|
|
18
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$37.6M
|
-$132K
|
-8,384
|
-0.4%
|
|
|
19
|
|
$34M
|
-$1.34M
|
-85,258
|
-5%
|
|
|
20
|
American Century Companies
Kansas City,
Missouri
|
$31.3M
|
-$975K
|
-61,837
|
-4%
|
|
|
21
|
Nuveen
Charlotte,
North Carolina
|
$25.8M
|
+$9.54M
|
+604,777
|
+79%
|
|
|
22
|
GW&K Investment Management
Boston,
Massachusetts
|
$22.1M
|
-$3.25M
|
-206,391
|
-15%
|
|
|
23
|
Driehaus Capital Management
Chicago,
Illinois
|
$20.7M
|
+$174K
|
+11,050
|
+1%
|
|
|
24
|
Charles Schwab
San Francisco,
California
|
$18.8M
|
+$542K
|
+34,368
|
+4%
|
|
|
25
|
Northern Trust
Chicago,
Illinois
|
$17.7M
|
+$182K
|
+11,514
|
+1%
|
|
